The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluating the intratumor microbiome of pancreatic ductal adenocarcinoma (PDAC) by analyzing the fresh frozen tissues obtained by endoscopic ultrasound-guided fine needle aspiration (EUS-FNA).
 
Shintaro Nakano
No Relationships to Disclose
 
Yasuyuki Kawamoto
Honoraria - Chugai Pharma; Daiichi Sankyo; Lilly; Merck; Taiho Pharmaceutical; Takeda
Research Funding - Japan Agency for Medical Research and Development
 
Kazuaki Harada
No Relationships to Disclose
 
Satoshi Yuki
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Lilly Japan; Merck Serono; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Ken Ito
No Relationships to Disclose
 
Rika Saitoh
No Relationships to Disclose
 
Takahiro Yamamura
No Relationships to Disclose
 
Hajime Hirata
No Relationships to Disclose
 
Yunosuke Takishin
No Relationships to Disclose
 
Ryutaro Furukawa
No Relationships to Disclose
 
Kousuke Nagai
No Relationships to Disclose
 
Masaki Kuwatani
Honoraria - Medicon
Research Funding - Japan Lifeline
 
Yoshito Komatsu
Honoraria - Asahi Kasei; Bayer Yakuhin; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Lilly; Medical Review Co., Ltd.; Merck; Mitsubishi Tanabe Pharma; Moroo Co.; Nipro Corporation; Ono Pharmaceutical; Otsuka; Sanofi/Aventis; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - A2 Healthcare; Astellas Pharma; Bayer Yakuhin; BeiGene (Inst); Daiichi Sankyo; Eisai; Incyte; IQvia; Lilly (Inst); Mediscience Planning; Merck Sharp & Dohme; NanoCarrier; Nipro Corporation (Inst); Ono Pharmaceutical; Parexel International Corporation.; Sanofi/Aventis; Shionogi; Sumitomo Dainippon; Sysmex; Taiho Pharmaceutical; Yakult Honsha
 
Naoya Sakamoto
Honoraria - Abbvie; Eisai; Gilead Sciences; Otsuka
Research Funding - Bayer; Chugai Pharma; Eisai; Otsuka; Takeda